Catalyst
Slingshot members are tracking this event:
Phase 3 data from CHERISH and ENDEAR (study evaluating nusinersen in infants with SMA) expected in 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IONS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 26, 2017
Occurred Source:
http://www.businesswire.com/news/home/20170126005351/en/Biogen-Reports-2016-Revenues-11.4-Billion
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Cherish, Endear, Nusinersen, Sma
